Global Pharma & Cosmetics Market Growth 2025-2031

Publication ID:

LPI07255053

Publication Date:

July 4, 2025

Pages:

135

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pharma & Cosmetics market size is predicted to grow from US$ 1856800 million in 2025 to US$ 2272360 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body"s resistance to disease or to help diagnose diseases.
The major players in global Pharma & Cosmetics market include Johnson & Johnson, Roche, Novartis, etc., and the market concentration rate is low. China and Japan are main markets, they occupy about 40% of the global market. Pharmaceuticals, OTC is the main application, which holds a share about 75%.
The 鈥淧harma & Cosmetics Industry Forecast鈥� looks at past sales and reviews total world Pharma & Cosmetics sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharma & Cosmetics sales for 2025 through 2031. With Pharma & Cosmetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma & Cosmetics industry.
This Insight Report provides a comprehensive analysis of the global Pharma & Cosmetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma & Cosmetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharma & Cosmetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma & Cosmetics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma & Cosmetics.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharma & Cosmetics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ointments
Creams
Gels
Others
Segmentation by Application:
Pharmaceuticals, OTC
Cosmetics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L' OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharma & Cosmetics market?
What factors are driving Pharma & Cosmetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharma & Cosmetics market opportunities vary by end market size?
How does Pharma & Cosmetics break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharma & Cosmetics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharma & Cosmetics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharma & Cosmetics by Country/Region, 2020, 2024 & 2031
2.2 Pharma & Cosmetics Segment by Type
2.2.1 Ointments
2.2.2 Creams
2.2.3 Gels
2.2.4 Others
2.3 Pharma & Cosmetics Sales by Type
2.3.1 Global Pharma & Cosmetics Sales Market Share by Type (2020-2025)
2.3.2 Global Pharma & Cosmetics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharma & Cosmetics Sale Price by Type (2020-2025)
2.4 Pharma & Cosmetics Segment by Application
2.4.1 Pharmaceuticals, OTC
2.4.2 Cosmetics
2.5 Pharma & Cosmetics Sales by Application
2.5.1 Global Pharma & Cosmetics Sale Market Share by Application (2020-2025)
2.5.2 Global Pharma & Cosmetics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharma & Cosmetics Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pharma & Cosmetics Breakdown Data by Company
3.1.1 Global Pharma & Cosmetics Annual Sales by Company (2020-2025)
3.1.2 Global Pharma & Cosmetics Sales Market Share by Company (2020-2025)
3.2 Global Pharma & Cosmetics Annual Revenue by Company (2020-2025)
3.2.1 Global Pharma & Cosmetics Revenue by Company (2020-2025)
3.2.2 Global Pharma & Cosmetics Revenue Market Share by Company (2020-2025)
3.3 Global Pharma & Cosmetics Sale Price by Company
3.4 Key Manufacturers Pharma & Cosmetics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharma & Cosmetics Product Location Distribution
3.4.2 Players Pharma & Cosmetics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharma & Cosmetics by Geographic Region
4.1 World Historic Pharma & Cosmetics Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharma & Cosmetics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharma & Cosmetics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharma & Cosmetics Market Size by Country/Region (2020-2025)
4.2.1 Global Pharma & Cosmetics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharma & Cosmetics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharma & Cosmetics Sales Growth
4.4 APAC Pharma & Cosmetics Sales Growth
4.5 Europe Pharma & Cosmetics Sales Growth
4.6 Middle East & Africa Pharma & Cosmetics Sales Growth
5 Americas
5.1 Americas Pharma & Cosmetics Sales by Country
5.1.1 Americas Pharma & Cosmetics Sales by Country (2020-2025)
5.1.2 Americas Pharma & Cosmetics Revenue by Country (2020-2025)
5.2 Americas Pharma & Cosmetics Sales by Type (2020-2025)
5.3 Americas Pharma & Cosmetics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharma & Cosmetics Sales by Region
6.1.1 APAC Pharma & Cosmetics Sales by Region (2020-2025)
6.1.2 APAC Pharma & Cosmetics Revenue by Region (2020-2025)
6.2 APAC Pharma & Cosmetics Sales by Type (2020-2025)
6.3 APAC Pharma & Cosmetics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharma & Cosmetics by Country
7.1.1 Europe Pharma & Cosmetics Sales by Country (2020-2025)
7.1.2 Europe Pharma & Cosmetics Revenue by Country (2020-2025)
7.2 Europe Pharma & Cosmetics Sales by Type (2020-2025)
7.3 Europe Pharma & Cosmetics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharma & Cosmetics by Country
8.1.1 Middle East & Africa Pharma & Cosmetics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharma & Cosmetics Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharma & Cosmetics Sales by Type (2020-2025)
8.3 Middle East & Africa Pharma & Cosmetics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharma & Cosmetics
10.3 Manufacturing Process Analysis of Pharma & Cosmetics
10.4 Industry Chain Structure of Pharma & Cosmetics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharma & Cosmetics Distributors
11.3 Pharma & Cosmetics Customer
12 World Forecast Review for Pharma & Cosmetics by Geographic Region
12.1 Global Pharma & Cosmetics Market Size Forecast by Region
12.1.1 Global Pharma & Cosmetics Forecast by Region (2026-2031)
12.1.2 Global Pharma & Cosmetics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharma & Cosmetics Forecast by Type (2026-2031)
12.7 Global Pharma & Cosmetics Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Pharma & Cosmetics Product Portfolios and Specifications
13.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Pharma & Cosmetics Product Portfolios and Specifications
13.2.3 Roche Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Pharma & Cosmetics Product Portfolios and Specifications
13.3.3 Novartis Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Pharma & Cosmetics Product Portfolios and Specifications
13.4.3 Pfizer Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Pharma & Cosmetics Product Portfolios and Specifications
13.5.3 Sanofi Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Pharma & Cosmetics Product Portfolios and Specifications
13.6.3 Eli Lilly Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 GSK
13.7.1 GSK Company Information
13.7.2 GSK Pharma & Cosmetics Product Portfolios and Specifications
13.7.3 GSK Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GSK Main Business Overview
13.7.5 GSK Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Pharma & Cosmetics Product Portfolios and Specifications
13.8.3 Bayer Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Merck & Co
13.9.1 Merck & Co Company Information
13.9.2 Merck & Co Pharma & Cosmetics Product Portfolios and Specifications
13.9.3 Merck & Co Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Merck & Co Main Business Overview
13.9.5 Merck & Co Latest Developments
13.10 L' OREAL
13.10.1 L' OREAL Company Information
13.10.2 L' OREAL Pharma & Cosmetics Product Portfolios and Specifications
13.10.3 L' OREAL Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 L' OREAL Main Business Overview
13.10.5 L' OREAL Latest Developments
13.11 Unilever
13.11.1 Unilever Company Information
13.11.2 Unilever Pharma & Cosmetics Product Portfolios and Specifications
13.11.3 Unilever Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Unilever Main Business Overview
13.11.5 Unilever Latest Developments
13.12 Procter & Gamble
13.12.1 Procter & Gamble Company Information
13.12.2 Procter & Gamble Pharma & Cosmetics Product Portfolios and Specifications
13.12.3 Procter & Gamble Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Procter & Gamble Main Business Overview
13.12.5 Procter & Gamble Latest Developments
13.13 Estee Lauder
13.13.1 Estee Lauder Company Information
13.13.2 Estee Lauder Pharma & Cosmetics Product Portfolios and Specifications
13.13.3 Estee Lauder Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Estee Lauder Main Business Overview
13.13.5 Estee Lauder Latest Developments
13.14 Kao
13.14.1 Kao Company Information
13.14.2 Kao Pharma & Cosmetics Product Portfolios and Specifications
13.14.3 Kao Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Kao Main Business Overview
13.14.5 Kao Latest Developments
13.15 Shiseido
13.15.1 Shiseido Company Information
13.15.2 Shiseido Pharma & Cosmetics Product Portfolios and Specifications
13.15.3 Shiseido Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Shiseido Main Business Overview
13.15.5 Shiseido Latest Developments
13.16 Beiersdorf
13.16.1 Beiersdorf Company Information
13.16.2 Beiersdorf Pharma & Cosmetics Product Portfolios and Specifications
13.16.3 Beiersdorf Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Beiersdorf Main Business Overview
13.16.5 Beiersdorf Latest Developments
13.17 Henkel
13.17.1 Henkel Company Information
13.17.2 Henkel Pharma & Cosmetics Product Portfolios and Specifications
13.17.3 Henkel Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Henkel Main Business Overview
13.17.5 Henkel Latest Developments
13.18 Shanghai Jahwa
13.18.1 Shanghai Jahwa Company Information
13.18.2 Shanghai Jahwa Pharma & Cosmetics Product Portfolios and Specifications
13.18.3 Shanghai Jahwa Pharma & Cosmetics Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Shanghai Jahwa Main Business Overview
13.18.5 Shanghai Jahwa Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂